PTGX
Protagonist Therapeutics, Inc.NASDAQStock$98.39-2.82 (-2.79%)Mkt Cap 6.3BP/E —Div Yield —Beta 2.11Vol 213.2KAvg Vol 713.2K
52W$42.01
$105.98
ETFs That Hold PTGX (Protagonist Therapeutics, Inc.)
1M
-1.48%
3M
+23.40%
6M
+25.15%
YTD
+12.86%
1Y
+115.67%
3Y
+317.79%
5Y
+239.98%
ETFs That Hold PTGX
Protagonist Therapeutics, Inc. is held by 130 ETFs. The largest position by market value is in IJR (iShares Core S&P Small-Cap ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| SCDS | JPMorgan Fundamental Data Science Small Core ETF | 0.50% |
| MMTM | State Street SPDR S&P 1500 Momentum Tilt ETF | 0.02% |
| AOM | iShares Core 40/60 Moderate Allocation ETF | 0.00% |
| VLU | State Street SPDR S&P 1500 Value Tilt ETF | 0.01% |
| AVLC | Avantis U.S. Large Cap Equity ETF | 0.00% |
| WDNA | WisdomTree BioRevolution Fund | 0.97% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.23% |
| SGRW | Harbor Active Small Cap Growth ETF (SGRW) | 0.43% |
| AOK | iShares Core 30/70 Conservative Allocation ETF | 0.00% |
| CSF | VictoryShares US Discovery Enhanced Volatility Wtd ETF | 0.05% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.18% |
| HDG | ProShares - Hedge Replication ETF | 0.03% |
| AVIE | Avantis Inflation Focused Equity ETF | 0.05% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.01% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
Excludes leveraged and inverse ETFs.
Frequently Asked Questions
How many ETFs hold PTGX?
Protagonist Therapeutics, Inc. (PTGX) is held by 130 ETFs (excluding leveraged and inverse funds). The largest position by market value is in IJR (iShares Core S&P Small-Cap ETF).
What is the largest ETF that holds PTGX?
By fund size, IJR (iShares Core S&P Small-Cap ETF) with $101.65B in AUM holds 0.36% of its portfolio in PTGX, representing $366.3M in market value.
What percentage of PBE is PTGX?
PTGX makes up 3.31% of PBE (Invesco Biotechnology & Genome ETF), making it one of the largest positions in that fund.
Is PTGX in the S&P 500?
PTGX is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.